BioXcel Therapeutics
BTAI
#9370
Rank
S$32.37 M
Marketcap
$0.79
Share price
1.18%
Change (1 day)
-76.07%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of June 2024 : S$73.29 M

According to BioXcel Therapeutics's latest financial reports the company has S$73.29 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$0.25 B-17.34%
2021-12-31S$0.31 B11.51%
2020-12-31S$0.28 B546.17%
2019-12-31S$43.6 M-24.8%
2018-12-31S$57.98 M4787.56%
2017-12-31S$1.18 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.37 B 408.98%๐Ÿ‡บ๐Ÿ‡ธ USA